ロード中...
A historical argument for regulatory failure in the case of Primodos and other hormone pregnancy tests
The drug Primodos and other hormone pregnancy tests (HPTs) remained on the British market for about a decade after they were first implicated, in 1967, as a possible cause of birth defects. In November 2017, an expert working group (EWG) set up by the Medicines and Healthcare Products Regulatory Age...
保存先:
| 出版年: | Reprod Biomed Soc Online |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6234516/ https://ncbi.nlm.nih.gov/pubmed/30456319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rbms.2018.09.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|